Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cyteir Therapeutics, Inc. (CYT)  
$3.02 0.00 (0.00%) as of 4:30 Fri 3/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,370,000
Market Cap: 106.82(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.74 - $3.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 284,366 284,366 284,366 366,717
Total Buy Value $845,707 $845,707 $845,707 $989,543
Total People Bought 1 1 1 3
Total Buy Transactions 2 2 2 7
Total Shares Sold 0 0 401,548 1,301,548
Total Sell Value $0 $0 $1,026,787 $3,726,787
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 14 15
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 59
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Romberger Timothy Director   –       •      –    2021-06-22 4 A $0.00 $0 D/D 79,060 369,448     -
   Novo A/s 10% Owner   –       –       •   2021-06-22 4 B $18.00 $4,999,986 D/D 277,777 4,840,413 2.45 -2%     
   Novo A/s 10% Owner   –       –       •   2021-06-22 4 A $0.00 $0 D/D 4,562,636 4,562,636     -
   Venrock Management Vii, Llc 10% Owner   –       –       •   2021-06-22 4 A $0.00 $0 I/I 3,259,025 3,259,025     -
   Gengos Andrew Chief Business OfficerOfficer   •       –      –    2021-06-17 3 IO $0.00 $0 D/D 0 73,534     -
   Zakrzewski Joseph S Director   –       •      –    2021-06-17 3 IO $0.00 $0 I/I 0 149,051     -
   Zakrzewski Joseph S Director   –       •      –    2021-06-17 3 IO $0.00 $0 D/D 0 77,267     -
   Romberger Timothy Director   –       •      –    2021-06-17 3 IO $0.00 $0 D/D 0 290,388     -
   Renschler Markus Md See RemarksOfficer   •       •      –    2021-06-17 3 IO $0.00 $0 D/D 0 841,954     -

  59 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed